Companies / Neurocrine Biosciences Inc / Activity
Activity — Neurocrine Biosciences Inc
192 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | Gorman Kevin Charles Director | Sell | Common Stock | $37.82M | -245K -32.40% | 511,293 0.50% of shares | high |
| May 19, 2026 | Gorman Kevin Charles Director | Exercise | Common Stock | $8.87M | +205K +37.20% | 756,381 0.74% of shares | low |
| Jan 16, 2026 | Gano Kyle CEO | Sell | Common Stock | $4.59M | -35K -19.77% | 140,407 0.14% of shares | medium |
| Feb 13, 2026 | Gorman Kevin Charles Director | Other | Common Stock | $4.27M | -34K -5.87% | 551,293 0.54% of shares | low |
| May 15, 2026 | Pops Richard F Director | Sell | Common Stock | $2.36M | -15K -30.32% | 34,480 0.03% of shares | medium |
| Feb 13, 2026 | Delaet Ingrid Executive | Other | Common Stock | $1.33M | -11K -39.86% | 16,225 0.02% of shares | low |
| Feb 13, 2026 | Onyia Jude Executive | Other | Common Stock | $1.33M | -11K -27.20% | 28,780 0.03% of shares | low |
| Jun 5, 2026 | Sherwin Stephen a Director | Sell | Common Stock | $1.29M | -8K -19.29% | 32,977 0.03% of shares | medium |
| Jan 16, 2026 | Gano Kyle CEO | Exercise | Common Stock | $1.24M | +35K +24.63% | 174,995 0.17% of shares | low |
| Jun 5, 2026 | Sherwin Stephen a Director | Sell | Common Stock | $1.14M | -7K -22.66% | 23,532 0.02% of shares | medium |
| Feb 13, 2026 | Benevich Eric Executive | Other | Common Stock | $1.11M | -9K -12.42% | 63,190 0.06% of shares | low |
| Jun 5, 2026 | Sherwin Stephen a Director | Sell | Common Stock | $970.9K | -6K -24.77% | 17,703 0.02% of shares | medium |
| Jun 5, 2026 | Sherwin Stephen a Director | Exercise | Common Stock | $804.6K | +15K +94.58% | 30,860 0.03% of shares | low |
| Jun 5, 2026 | Sherwin Stephen a Director | Exercise | Common Stock | $797.9K | +10K +32.40% | 40,860 0.04% of shares | low |
| May 15, 2026 | Pops Richard F Director | Exercise | Common Stock | $718.4K | +15K +43.50% | 49,480 0.05% of shares | low |
| Feb 13, 2026 | Boyer David W. Executive | Other | Common Stock | $667.5K | -5K -31.71% | 11,581 0.01% of shares | low |
| Feb 13, 2026 | Cooke Julie Executive | Other | Common Stock | $667.5K | -5K -13.60% | 34,170 0.03% of shares | low |
| Feb 13, 2026 | Abernethy Matt Executive | Other | Common Stock | $667.5K | -5K -10.70% | 44,881 0.04% of shares | low |
| Feb 13, 2026 | Gano Kyle CEO | Other | Common Stock | $667.5K | -5K -3.44% | 150,815 0.15% of shares | low |
| Feb 13, 2026 | Lippoldt Darin Executive | Other | Common Stock | $667.5K | -5K -8.89% | 55,094 0.05% of shares | low |
| Nov 28, 2025 | Benevich Eric Executive | Exercise | Common Stock | $461.8K | +13K +28.58% | 57,723 0.06% of shares | low |
| Jun 5, 2026 | Sherwin Stephen a Director | Sell | Common Stock | $419.2K | -3K -7.73% | 30,428 0.03% of shares | medium |
| Jan 31, 2026 | Gorman Kevin Charles Director | Other | Common Stock | $387.1K | -3K -0.55% | 516,893 0.51% of shares | low |
| Feb 13, 2026 | Gorman Kevin Charles Director | Other | Common Stock | $375.3K | -3K -0.58% | 519,473 0.51% of shares | low |
| Feb 13, 2026 | Gorman Kevin Charles Director | Other | Common Stock | $360.1K | -3K -0.55% | 521,949 0.51% of shares | low |
| Feb 12, 2026 | Gano Kyle CEO | Other | Common Stock | $326.0K | -3K -1.81% | 144,013 0.14% of shares | low |
| Jun 5, 2026 | Sherwin Stephen a Director | Sell | Common Stock | $308.4K | -2K -10.41% | 15,860 0.02% of shares | medium |
| Jan 16, 2026 | Gano Kyle CEO | Sell | Common Stock | $240.5K | -2K -1.27% | 140,407 0.14% of shares | medium |
| Jan 31, 2026 | Gano Kyle CEO | Other | Common Stock | $215.0K | -2K -1.10% | 141,754 0.14% of shares | low |
| Jan 31, 2026 | Abernethy Matt Executive | Other | Common Stock | $186.1K | -1K -3.56% | 37,097 0.04% of shares | low |
| Feb 13, 2026 | Onyia Jude Executive | Other | Common Stock | $182.0K | -1K -6.96% | 19,600 0.02% of shares | low |
| Jan 31, 2026 | Lippoldt Darin Executive | Other | Common Stock | $181.6K | -1K -2.72% | 47,792 0.05% of shares | low |
| Feb 13, 2026 | Onyia Jude Executive | Other | Common Stock | $180.2K | -1K -7.33% | 18,349 0.02% of shares | low |
| Jan 31, 2026 | Benevich Eric Executive | Other | Common Stock | $175.8K | -1K -2.39% | 52,755 0.05% of shares | low |
| Feb 12, 2026 | Onyia Jude Executive | Other | Common Stock | $175.5K | -1K -7.69% | 17,111 0.02% of shares | low |
| Feb 13, 2026 | Abernethy Matt Executive | Other | Common Stock | $171.9K | -1K -3.32% | 40,291 0.04% of shares | low |
| Feb 13, 2026 | Gano Kyle CEO | Other | Common Stock | $171.9K | -1K -0.94% | 146,225 0.14% of shares | low |
| Jan 31, 2026 | Boyer David W. Executive | Other | Common Stock | $161.8K | -1K -20.15% | 4,713 <0.01% of shares | low |
| Feb 13, 2026 | Abernethy Matt Executive | Other | Common Stock | $150.2K | -1K -3.00% | 39,110 0.04% of shares | low |
| Feb 13, 2026 | Gano Kyle CEO | Other | Common Stock | $150.2K | -1K -0.83% | 145,044 0.14% of shares | low |
| Feb 12, 2026 | Abernethy Matt Executive | Other | Common Stock | $141.7K | -1K -2.93% | 38,079 0.04% of shares | low |
| Feb 13, 2026 | Benevich Eric Executive | Other | Common Stock | $139.5K | -1K -1.98% | 55,540 0.05% of shares | low |
| Feb 13, 2026 | Lippoldt Darin Executive | Other | Common Stock | $139.5K | -1K -2.18% | 50,504 0.05% of shares | low |
| Jan 31, 2026 | Cooke Julie Executive | Other | Common Stock | $135.7K | -997 -3.49% | 27,602 0.03% of shares | low |
| Feb 13, 2026 | Lippoldt Darin Executive | Other | Common Stock | $135.2K | -1K -2.15% | 49,545 0.05% of shares | low |
| Feb 12, 2026 | Benevich Eric Executive | Other | Common Stock | $133.2K | -1K -1.98% | 53,678 0.05% of shares | low |
| Feb 13, 2026 | Benevich Eric Executive | Other | Common Stock | $131.3K | -1K -1.90% | 54,581 0.05% of shares | low |
| Feb 13, 2026 | Boyer David W. Executive | Other | Common Stock | $121.4K | -978 -12.27% | 6,991 <0.01% of shares | low |
| Jan 8, 2026 | Lippoldt Darin Executive | Exercise | Common Stock | $120.5K | +3K +7.72% | 46,754 0.05% of shares | low |
| Feb 12, 2026 | Lippoldt Darin Executive | Other | Common Stock | $119.0K | -967 -1.95% | 48,617 0.05% of shares | low |